id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-4503	Gargiulo, Luigi; Ibba, Luciano; Narcisi, Alessandra; Giordano, Silvia; Maronese, Carlo A.; Martora, Fabrizio; Repetto, Federica; Paolino, Giovanni; Balato, Anna; Burlando, Martina; Dapavo, Paolo; Dini, Valentina; Guarneri, Claudio; Marzano, Angelo V.; Megna, Matteo; Mercuri, Santo R.; Costanzo, Antonio; Valenti, Mario	Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study	2024	7	.pdf	application/pdf	4276	297	55	Risankizumab failed to meet the primary endpoint in a Phase 2 clinical trial enrolling patients with severe HS Furthermore, another study assessed a good response to brodalumab in HS patients considering sonographic bio- markers (epidermal thickness and power-doppler) and cor- relating them with different clinical and patient-reported outcomes [26].	cache/dpc-4503.pdf	txt/dpc-4503.txt